Obizur (susoctocog alfa) / Ipsen, Takeda  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Obizur (susoctocog alfa) / Takeda, Ipsen
NCT01434511 / 2011-001899-18: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

Terminated
3
1
Europe, US, RoW
OBI-1
Baxalta now part of Shire
Hemophilia A
07/13
07/13
NCT02895945 / 2015-005521-39: BAX 802 in CHA With Inhibitors

Terminated
3
8
Europe, Canada, US, RoW
Antihemophilic Factor (Recombinant), Porcine Sequence (BAX 802), BAX 802, recombinant porcine factor VIII, Obizur, rpFVIII
Baxalta now part of Shire, Baxalta Innovations GmbH, now part of Shire
Hemophilia A
01/21
01/21
NCT01178294 / 2011-000181-34: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A

Checkmark
Jan 2015 - Jan 2015: 
Checkmark
Nov 2014 - Nov 2014: 
Checkmark
More
Completed
2/3
29
Europe, Canada, US, RoW
OBI-1
Baxalta now part of Shire
Acquired Hemophilia A
07/13
10/13
NCT04580407: Study of TAK-672 in Participants With Acquired Hemophilia A

Completed
2/3
5
Japan
TAK-672, rpFVIII, TAK-672, Obizur
Takeda
Acquired Hemophilia A
11/22
11/22

Download Options